Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01175980 · OUTCOME

Expression Level of HR23B

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma · Source last updated 2020-08-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 180 days after the last dose of vorinostat maximum treatment duration= 24 months

What was measured

Exact logistic modeling investigation would yield a point and 90% CI estimate of the odds ratio for response.

Analysis population: HR23B was not measured in any participant.

Groups in this outcome

Treatment (Vorinostat)

Patients receive vorinostat PO QD on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Vorinostat: Given PO

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Vorinostat)0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
Exact logistic modeling investigation would yield a point and 90% CI estimate of the odds ratio for response.
groups
  1. description
    Patients receive vorinostat PO QD on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Vorinostat: Given PO
    id
    OG000
    title
    Treatment (Vorinostat)
population Description
HR23B was not measured in any participant.
reporting Status
POSTED
time Frame
Up to 180 days after the last dose of vorinostat maximum treatment duration= 24 months
title
Expression Level of HR23B
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice